Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Germline p16 mutations in familial melanoma.

Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark WH Jr, Tucker MA, Dracopoli NC.

Nat Genet. 1994 Sep;8(1):15-21.

PMID:
7987387
2.

Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma.

Platz A, Hansson J, Månsson-Brahme E, Lagerlof B, Linder S, Lundqvist E, Sevigny P, Inganäs M, Ringborg U.

J Natl Cancer Inst. 1997 May 21;89(10):697-702.

3.

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.

Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J, et al.

Nat Genet. 1994 Sep;8(1):23-6.

PMID:
7987388
4.

CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.

Ruiz A, Puig S, Malvehy J, Lázaro C, Lynch M, Gimenez-Arnau AM, Puig L, Sánchez-Conejo J, Estivill X, Castel T.

J Med Genet. 1999 Jun;36(6):490-3.

5.

Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma.

Liu L, Lassam NJ, Slingerland JM, Bailey D, Cole D, Jenkins R, Hogg D.

Oncogene. 1995 Jul 20;11(2):405-12.

PMID:
7624155
6.

Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families.

Yakobson E, Shemesh P, Azizi E, Winkler E, Lassam N, Hogg D, Brookes S, Peters G, Lotem M, Zlotogorski A, Landau M, Safro M, Shafir R, Friedman E, Peretz H.

Eur J Hum Genet. 2000 Aug;8(8):590-6.

7.

The current situation with regard to human melanoma and genetic inferences.

Hayward NK.

Curr Opin Oncol. 1996 Mar;8(2):136-42. Review.

PMID:
8727306
8.

Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds.

Walker GJ, Hussussian CJ, Flores JF, Glendening JM, Haluska FG, Dracopoli NC, Hayward NK, Fountain JW.

Hum Mol Genet. 1995 Oct;4(10):1845-52.

PMID:
8595405
9.

Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds.

Gruis NA, van der Velden PA, Sandkuijl LA, Prins DE, Weaver-Feldhaus J, Kamb A, Bergman W, Frants RR.

Nat Genet. 1995 Jul;10(3):351-3.

PMID:
7670475
10.

[From gene to disease; from p16 to melanoma].

Gruis NA, Bergman W.

Ned Tijdschr Geneeskd. 2000 Oct 28;144(44):2100-2. Review. Dutch.

PMID:
11103670
11.

Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds.

Holland EA, Beaton SC, Becker TM, Grulet OM, Peters BA, Rizos H, Kefford RF, Mann GJ.

Oncogene. 1995 Dec 7;11(11):2289-94.

PMID:
8570179
12.

Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22.

Cannon-Albright LA, Goldgar DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW, Hegi ME, Wiseman RW, Petty EM, Bale AE, et al.

Science. 1992 Nov 13;258(5085):1148-52.

PMID:
1439824
13.
14.

Constitutional alterations in p16 in patients with uveal melanoma.

Wang X, Egan KM, Gragoudas ES, Kelsey KT.

Melanoma Res. 1996 Dec;6(6):405-10.

PMID:
9013477
15.

Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus.

Lee JY, Dong SM, Shin MS, Kim SY, Lee SH, Kang SJ, Lee JD, Kim CS, Kim SH, Yoo NJ.

Biochem Biophys Res Commun. 1997 Aug 28;237(3):667-72.

PMID:
9299424
16.

Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.

Bahuau M, Vidaud D, Jenkins RB, Bièche I, Kimmel DW, Assouline B, Smith JS, Alderete B, Cayuela JM, Harpey JP, Caille B, Vidaud M.

Cancer Res. 1998 Jun 1;58(11):2298-303.

17.

Prevalence of 9p21 deletions in UK melanoma families.

Mistry SH, Taylor C, Randerson-Moor JA, Harland M, Turner F, Barrett JH, Whitaker L, Jenkins RB, Knowles MA, Bishop JA, Bishop DT.

Genes Chromosomes Cancer. 2005 Nov;44(3):292-300.

PMID:
16032697
18.
19.

High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.

Borg A, Sandberg T, Nilsson K, Johannsson O, Klinker M, Måsbäck A, Westerdahl J, Olsson H, Ingvar C.

J Natl Cancer Inst. 2000 Aug 2;92(15):1260-6.

20.

Familial uveal melanoma: absence of germline mutations involving the cyclin-dependent kinase-4 inhibitor gene (p16).

Singh AD, Croce CM, Wary KK, Shields JA, Donoso LA, Shields CL, Huebner K, Ohta M.

Ophthalmic Genet. 1996 Mar;17(1):39-40. No abstract available.

PMID:
8740697
Items per page

Supplemental Content

Write to the Help Desk